NTNataliya A. Teteneva

Nataliya A. Teteneva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nataliya A. Teteneva has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Toolbox of FRET-based c-di-GMP biosensors and its FRET-To-Sort application for genome-wide mapping of c-di-GMP regulation

    by Liyun Wang, Gabriele Malengo, Ananda Sanches-Medeiros, Xuanlin Chen, Julian Pietsch, Nataliya Teteneva, Silvia González Sierra, Ming C. Hammond, Victor Sourjik

    C-di-GMP is a widespread second messenger that coordinates transitions between different lifestyles in bacteria. Levels of c-di-GMP are controlled by complex regulatory networks, and they can vary dynamically over a wide range of concentrations. To enable studies of c-di-GMP regulation under a variety of conditions, here we construct and characterize a large set of FRET-based c-di-GMP biosensors that undergo large FRET signal changes and display a stepwise coverage of diverse binding affinities, thus capable of sensitively detecting diverse cellular c-di-GMP concentrations. We subsequently apply different-affinity FRET biosensors from this toolbox to systematically investigate genome-wide network of c-di-GMP regulation in planktonic Escherichia coli cells by establishing FRET-To-Sort, which relies on FRET-based cell sorting of a barcoded transposon library. We observe prominent enrichment of mutations in two classes of flagellar genes among those affecting c-di-GMP levels, and demonstrate that inhibited flagellar rotation reduces biosynthesis of c-di-GMP due to increased proton motive force.


  • Open Access

    Genome-wide screen of genetic determinants that govern Escherichia coli growth and persistence in lake water

    by Nataliya Teteneva, Ananda Sanches-Medeiros, Victor Sourjik

    Although enteric bacteria normally reside within the animal intestine, the ability to persist extraintestinally is an essential part of their overall lifestyle, and it might contribute to transmission between hosts. Despite this potential importance, few genetic determinants of extraintestinal growth and survival have been identified, even for the best-studied model, Escherichia coli. In this work, we thus used a genome-wide library of barcoded transposon insertions to systematically identify functional clusters of genes that are crucial for E. coli fitness in lake water. Our results revealed that inactivation of pathways involved in maintaining outer membrane integrity, nucleotide biosynthesis, and chemotaxis negatively affected E. coli growth or survival in this extraintestinal environment. In contrast, inactivation of another group of genes apparently benefited E. coli growth or persistence in filtered lake water, resulting in higher abundance of these mutants. This group included rpoS, which encodes the general stress response sigma factor, and genes encoding several other global transcriptional regulators and RNA chaperones, as well as several poorly annotated genes. Based on this co-enrichment, we identified these gene products as novel positive regulators of RpoS activity. We further observed that, despite their enhanced growth, E. coli mutants with inactive RpoS had reduced viability in lake water, and they were not enriched in the presence of the autochthonous microbiota. This highlights the duality of the general stress response pathway for E. coli growth outside the host.


  • Open Access

    Multiple Drug-Induced Stress Responses Inhibit Formation of Escherichia coli Biofilms

    by Nataliya A. Teteneva, Sergey V. Mart’yAnov, María Esteban-López, Jörg Kahnt, Timo Glatter, Alexander I. Netrusov, Vladimir K. Plakunov, Victor Sourjik

    The prevention of bacterial biofilm formation is one of the major current challenges in microbiology. Here, by systematically screening a large number of approved drugs for their ability to suppress biofilm formation by Escherichia coli , we identified a number of prospective antibiofilm compounds. We further demonstrated different mechanisms of action for individual compounds, from induction of replicative stress to disbalance of cation homeostasis to inhibition of bacterial attachment to the surface. Our work demonstrates the potential of drug repurposing for the prevention of bacterial biofilm formation and suggests that also for other bacteria, the activity spectrum of antibiofilm compounds is likely to be broad.


  • Open Access

    Draft Genome Sequence of Kytococcus schroeteri Strain H01, Isolated from Human Skin

    by Amine M. Boukerb, Magalie Robert, Nataliya A. Teteneva, Natalia D. Danilova, Marina V. Zhurina, Sergey V. Mart’yAnov, Vladimir K. Plakunov, Marc G. J. Feuilloley, Andrei V. Gannesen

    Kytococcus schroeteri strain H01 was isolated from the skin of a healthy volunteer who underwent erythromycin treatment for a skin disorder 1 year prior. The draft genome consists of 2.38 Mb, a G+C content of 73.06%, and 2,221 protein coding sequences. This is the first genome characterization of a K. schroeteri strain isolated from human skin.


  • Niclosamide as a promising antibiofilm agent

    by M. V. Zhurina, A. V. Gannesen, S. V. Mart’YAnov, N. A. Teteneva, V. Y. Shtratnikova, V. K. Plakunov

    Search for inexpensive efficient compounds with antibiofilm activity, which could be applied both for treatment of biofilm-associated infections and in other cases requiring biofilm elimination, is presently of importance. For this purpose we chose niclosamide. Niclosamide is a widespread and available anthelmintic drug, which was also recently shown to suppress bacterial growth. High antibiofilm activity of niclosamide against a range of gram-positive bacteria isolated from different ecological niches was shown. According to our results, niclosamide may be a promising component of composite antibiofilm preparations.


  • Controlling of microbial biofilms formation: Anti- and probiofilm agents

    by V. K. Plakunov, S. V. Mart’YAnov, N. A. Teteneva, M. V. Zhurina

    Controlling the formation and reconstruction of microbial biofilms is of ever increasing importance for the ecological, medical, and biotechnological aspects of biofilm studies. The goal of this review was to provide systematization and analysis of the results obtained in recent years on the modes and mechanisms of the stimulatory or inhibitory effect of extreme factors and biocidal agents on biofilm formation. Special attention is paid to controlling the formation of medically (infective diseases, implant biofouling) and technologically or biotechnologically important biofilms (bioremediation, biocorrosion, and biosynthesis of biologically active compounds).